Targeting Human Papillomavirus-Associated Cancer by Oncoprotein-Specific Recombinant Antibodies

In recent decades, recombinant antibodies against specific antigens have shown great promise for the therapy of infectious diseases and cancer. Human papillomaviruses (HPVs) are involved in the development of around 5% of all human cancers and HPV16 is the high-risk genotype with the highest prevale...

Descripción completa

Detalles Bibliográficos
Autores principales: Donà, Maria Gabriella, Di Bonito, Paola, Chiantore, Maria Vincenza, Amici, Carla, Accardi, Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431386/
https://www.ncbi.nlm.nih.gov/pubmed/34502053
http://dx.doi.org/10.3390/ijms22179143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431386/
https://www.ncbi.nlm.nih.gov/pubmed/34502053
http://dx.doi.org/10.3390/ijms22179143

Ejemplares similares